These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
148 related items for PubMed ID: 8279161
1. Sumatriptan--a new treatment of migraine. Neighbor ML. West J Med; 1993 Nov; 159(5):597-8. PubMed ID: 8279161 [No Abstract] [Full Text] [Related]
2. [Sumatriptan ++ in the treatment of migraine and cluster headache]. Láinez JM, Monzón MJ. Rev Neurol; 1995 Nov; 23 Suppl 2():S166-78. PubMed ID: 7497282 [No Abstract] [Full Text] [Related]
3. [The role of agonists of serotonin receptor 5HT1B/D in pathogenesis and treatment of migraine attacks]. Stepień A. Pol Merkur Lekarski; 1999 Jun; 6(36):341-3. PubMed ID: 10481551 [Abstract] [Full Text] [Related]
5. [Sumatriptan in treatment of migraine and its efficacy and tolerance in self-assessment by patients]. Prusiński A, Barliński J. Pol Tyg Lek; 1996 Mar; 51(10-13):187-9. PubMed ID: 8927561 [No Abstract] [Full Text] [Related]
6. [The efficacy of subcutaneous sumatriptan for the treatment of migraine attack]. Stepień A. Pol Merkur Lekarski; 1999 Jun; 6(36):326-7. PubMed ID: 10481546 [Abstract] [Full Text] [Related]
7. Upregulated expression of peripheral serotonergic receptors in migraine and cluster headache by sumatriptan. Martelletti P, Stirparo G, Rinaldi C, Giacovazzo M. Int J Clin Pharmacol Res; 1994 Jun; 14(5-6):165-75. PubMed ID: 7672873 [Abstract] [Full Text] [Related]
8. Two replicate randomized, double-blind, placebo-controlled trials of the time to onset of pain relief in the acute treatment of migraine with a fast-disintegrating/rapid-release formulation of sumatriptan tablets. Sheftell FD, Dahlöf CG, Brandes JL, Agosti R, Jones MW, Barrett PS. Clin Ther; 2005 Apr; 27(4):407-17. PubMed ID: 15922814 [Abstract] [Full Text] [Related]
9. [18 months long-term analysis of effectiveness, safety and tolerance of sumatriptan s.c. in acute therapy of migraine attacks]. Göbel H, Stolze H, Heinze A, Dworschak M, Heuss D, Christiani K, Lindner V. Nervenarzt; 1996 Jun; 67(6):471-83. PubMed ID: 8767202 [Abstract] [Full Text] [Related]
13. Sumatriptan suppositories for the acute treatment of migraine. S2B351 Study Group. Tepper SJ, Cochran A, Hobbs S, Woessner M. Int J Clin Pract; 1998 Jun; 52(1):31-5. PubMed ID: 9536565 [Abstract] [Full Text] [Related]
16. A randomized, double-blind, placebo-controlled trial of the efficacy and tolerability of a 4-mg dose of subcutaneous sumatriptan for the treatment of acute migraine attacks in adults. Wendt J, Cady R, Singer R, Peters K, Webster C, Kori S, Byrd S. Clin Ther; 2006 Apr; 28(4):517-26. PubMed ID: 16750463 [Abstract] [Full Text] [Related]
19. Subcutaneous sumatriptan for the treatment of migraine: humanistic, economic, and clinical consequences. Cohen JA, Beall DG, Miller DW, Beck A, Pait G, Clements BD. Fam Med; 1996 Mar; 28(3):171-7. PubMed ID: 8900548 [Abstract] [Full Text] [Related]
20. [Greater value of sumatriptan over ergot alkaloids still not proven]. van Luijn JC. Ned Tijdschr Geneeskd; 1993 Dec 04; 137(49):2554-8. PubMed ID: 8272145 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]